Ophthalmology is approaching a Renaissance as novel therapies are being developed to meet a variety of unmet needs that, with current therapies, may progress to blindness. Oculis S.A. entered this space a few years ago, determined to identify those gaps. Rather than begin with a solution in search of a problem, it started with a thorough […]

Amyotrophic lateral sclerosis (ALS) is a devastating disease. For years, pharmaceutical companies have been striving to develop therapies to help patients who face certain death but have mostly come up short. Now though, there is a renaissance in ALS drug development with multiple shots being taken on goal, including Clene, Inc.’s add-on treatment, CNM-Au8, which is […]

180 Life Sciences (NASDAQ:ATNF) has three families of novel biologic drugs in synchronized stages of development, addressing separate areas of inflammation, fibrosis and pain, for which there are no effective therapies. “There are some 60 million people in the U.S. suffering from inflammatory diseases and the pain that goes along with them,” James Woody, M.D., Ph.D., […]